- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Johnson & Johnson
+ Add to WatchlistJNJ:US
88.0100 USD 0.00000.00%As of 20:04:07 ET on 05/20/2013.
Snapshot for Johnson & Johnson (JNJ)
| Open: | - | Day's Range: | - | Volume: | 7,235,972 |
|---|---|---|---|---|---|
| Previous Close: | 88.0900 | 52wk Range: | 61.7100 - 88.2000 | 1-Yr Rtn: | +43.65% |
Key Statistics for JNJ
| Current P/E Ratio (ttm) | 16.9903 |
|---|---|
| Estimated P/E(12/2013) | 16.2620 |
| Relative P/E vs. SPX | 1.0420 |
| Earnings Per Share (USD) (ttm) | 5.1800 |
| Est. EPS (USD) (12/2013) | 5.4120 |
| Est. PEG Ratio | 2.3165 |
| Market Cap (M USD) | 247,210.14 |
| Shares Outstanding (M) | 2,808.89 |
| 30 Day Average Volume | 9,489,196 |
| Price/Book (mrq) | 3.6902 |
| Price/Sale (ttm) | 3.5702 |
| Dividend Indicated Gross Yield | 3.00% |
| Cash Dividend (USD) | 0.6600 |
| Last Dividend | 05/23/2013 |
| 5 Year Dividend Growth | 8.01% |
| Next Earnings Announcement | 07/17/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for JNJ
Company Profile & Key Executives for JNJ
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
| Alex GorskyChairman/CEO | Paulus StoffelsChief Scientific Officer |
| Sandra E Peterson "Sandi"Chairman:Worldwide | Dominic J CarusoVP:Finance/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
JNJ News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page